Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prochlorperazine 5mg tablets
0406000T0AAAGAG
|
Prochlpzine maleate | Prochlorperazine maleate | Central Nervous System | 187,203 |
|
Prochlorperazine 3mg buccal tablets
0406000T0AAAKAK
|
Prochlpzine maleate | Prochlorperazine maleate | Central Nervous System | 46,004 |
|
Prochlorperazine 25mg suppositories
0406000T0AAAFAF
|
Prochlpzine maleate | Prochlorperazine maleate | Central Nervous System | 1 |
|
Prochlorperazine 25mg tablets
0406000T0AAAHAH
|
Prochlpzine maleate | Prochlorperazine maleate | Central Nervous System | No data available |
|
Prochlorperazine 5mg suppositories
0406000T0AAAEAE
|
Prochlpzine maleate | Prochlorperazine maleate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.